LEADER 03995nam  22006015  450 
001 9910647383103321
005 20231006194456.0
010   $a981-19-6442-4
024 7 $a10.1007/978-981-19-6442-8
035   $a(MiAaPQ)EBC7188515
035   $a(Au-PeEL)EBL7188515
035   $a(CKB)26076454600041
035   $a(DE-He213)978-981-19-6442-8
035   $a(PPN)267811489
035   $a(EXLCZ)9926076454600041
100   $a20230130d2023      u|             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGallbladder cancer $ecurrent treatment options  /$fedited by Vijay Kumar Shukla, Manoj Pandey, Ruhi Dixit
210  1$aSingapore :$cSpringer Nature Singapore :$cImprint: Springer,$d2023.
215   $a1 online resource (355 pages)
311 08$aPrint version: Kumar Shukla, Vijay Gallbladder Cancer Singapore : Springer,c2023 9789811964411 
320   $aIncludes bibliographical references.
327   $aGallbladder Cancer: Current treatment options and therapeutics -- Surgical Management of Gallbladder Cancer Patients -- Conventional therapy in Gallbladder Cancer -- Adjuvant Therapy following Surgical Treatment of Gallbladder Cancer -- Incidental gallbladder cancer: the role of routine versus selective histopathological examination of gallbladder specimens after cholecystectomy -- Minimally Invasive Surgery for Management of Gallbladder Cancer -- Thickwalled Gallbladder: Differential diagnosis and surgical approach to a thickened gallbladder -- Management of incidentally detected gallbladder cancer after cholecystectomy -- Adjuvant treatment in radically resected gallbladder cancer -- A look at emerging therapeutic targets for gallbladder cancer: a multi-omics approach -- MicroRNA and their role in Carcinoma Gallbladder -- Gallbladder cancer: Epigenetic landscape, Targeted therapy and Prospect of Epitherapy -- Targeted treatment of Gallbladder cancer -- Molecular pathways in Gallbladder cancer as potential therapeutic target -- Targeted Therapy: Molecular Pathology and Targets of Gallbladder Cancer -- Targeted Therapies in Gallbladder Cancer: Current Status and Future Perspectives -- Integrative omics - the roadmap for gallbladder biomarkers identification -- Anti-EGFR Therapy in Gall Bladder Cancer.
330   $aThe book discusses the recent progress in understanding the therapeutic targets for gallbladder cancer to provide opportunities for research and for developing innovative strategies that may enhance the benefit of conventional chemotherapy. The book focuses on identifying candidate molecules and the overall status of the targeted therapies available for gallbladder cancer, as there is an urgent need to discover new molecular targets that can guide the emergence of new treatment strategies to improve patient outcomes and act as biomarkers for the early detection of diseases. Recently, new treatment therapeutics targets for gallbladder cancer patients have been identified and the field is evolving rapidly. The book is relevant for the clinical researcher, surgeon, scientist and academician.
606   $aGallbladder$xCancer$xTreatment
606   $aOncology
606   $aSurgery
606   $aGallbladder Neoplasms$xtherapy$3(DNLM)D005706Q000628
606   $aMedical Oncology$3(DNLM)D008495
606   $aGeneral Surgery$3(DNLM)D013502
606   $aTherapeutics$3(DNLM)D013812
615  0$aGallbladder$xCancer$xTreatment.
615  0$aOncology.
615  0$aSurgery.
615 12$aGallbladder Neoplasms$xtherapy
615 12$aMedical Oncology
615 22$aGeneral Surgery
615 22$aTherapeutics
676   $a616.3
702   $aPandey$b Manoj
702   $aDixit$b Ruhi
702   $aKumar Shukla$b Vijay
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910647383103321
996   $aGallbladder Cancer$93009663
997   $aUNINA